ZZZe-Hao Zhuang

Ze-Hao Zhuang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ze-Hao Zhuang has a total of 79 co-authors. Here are the top co-authors by number of shared publications:

  • Jing-Jing Wei

    Department of Endoscopy Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China

    9 shared publications
  • Jing-Jing Wei

    Department of Endoscopy Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China

    4 shared publications
  • Ou Qian

    Endoscopy Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China

    4 shared publications
  • Ting-Ting Lian

    Department of Endoscopy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China

    4 shared publications
  • Ying Jiang

    Department of Endoscopy, The First Affiliated Hospital of Fujian Medical University, Fujian, P.R. China

    4 shared publications
  • Du-Peng Tang

    Department of Endoscopy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China

    3 shared publications

Latest Publications

  • Open Access

    Establishment of an enteral nutrition pathway for malignant esophageal obstruction using combined esophageal stenting and gastrostomy

    by Wennan Huang, Tingting Lian, Hanxi Chen, Biqing Lin, Ou Qian, Dong Lu, Zehao Zhuang

    Malnutrition is common in patients with advanced esophageal cancer and is associated with poor outcomes. While esophageal stenting can relieve dysphagia, o

  • ASO Visual Abstract: Endoscopic Image-Based Prediction of Esophageal Stenosis After Endoscopic Submucosal Dissection Using Mucosal Defect

    by Wei Lin, Yi-Zhi Liang, Dun-Huang Peng, Jun-Xi Wang, Si-Fu Huang, Jing-Jing Wei, Jiang-Mu Chen, Wen-Ming Liu, Tai-Yong Fang, Ze-Hao Zhuang

  • Open Access

    Endoscopic Image-Based Prediction of Esophageal Stenosis after ESD Using Mucosal Defect Metrics

    by Wei Lin, Yi-Zhi Liang, Dun-Huang Peng, Jun-Xi Wang, Si-Fu Huang, Jing-Jing Wei, Jiang-Mu Chen, Wen-Ming Liu, Tai-Yong Fang, Ze-Hao Zhuang

    Background: Stricture is a major adverse event following esophageal endoscopic submucosal dissection (ESD). Although postoperative esophageal stenosis after ESD is clearly associated with large mucosal defects, there are no quantitative criteria for the degree of the defect. We aimed to examine the predictive factors associated with the development of esophageal stenosis after ESD, and to explore quantitative indicators for predicting postoperative stenosis. Patients and Methods: A retrospective analysis of endoscopic data from patients with esophageal ESD was conducted. The area and perimeter of the resected mucosa defect were measured by Image Pro Plus 6.0. Logistic regression, receiver operating characteristic (ROC) curve, and nomogram model were adopted for analysis. Results: The median area of resected mucosal defect was 527.74 mm2 (IQR 322.80–823.48), the median perimeter was 91.75 mm (IQR 71.69–118.32), and the median circumferential ratio was 33% (IQR 20–40). Owing to collinearity between the perimeter and area of the resected mucosal defect, these variables were analyzed individually in the multivariate analysis (r = 0.958, P < 0.001). All three factors mentioned above were identified as independent risk factors for postoperative esophageal stenosis (P < 0.05), while intraoperative muscularis propria injury was not (P > 0.05). On the basis of the above results, prediction models were constructed and validated internally. The concordance statistics (C-statistics) of the training and validation sets including perimeter or area were 0.875 and 0.830 and 0.747 and 0.835, respectively. The Hosmer–Lemeshow goodness-of-fit test results were not significant (P > 0.05). Conclusions: Accurate quantification of the area and perimeter of resected mucosa by image analysis technology can accurately predict esophageal stenosis after ESD.


  • Colonoscopic administration of probiotics to treat irritable bowel syndrome with predominant diarrhea: a randomized placebo-controlled clinical trial

    by Jing-Jing Wei, Pei-Hong Zhang, Zhi-Yong Yang, Lu-Peng Liu, Ting-Ting Lian, Hajime Isomoto, Ze-Hao Zhuang

    Background To investigate the effects of colonoscopic administration of probiotics on patients with irritable bowel syndrome with predominant diarrhea (IBS-D) by a single-center, randomized-controlled trial. Methods Consecutive outpatients at the First Affiliated Hospital of Fujian Medical University who met the Rome IV diagnostic criteria for IBS-D (n = 22) and healthy subjects (n = 10) from January 2017 to January 2018 were enrolled. IBS-D patients were randomly divided into either the probiotics or the placebo group. During the colonoscopy examination, a suspension of live combined Bifidobacterium with Lactobacillus tablets and normal saline was sprayed into the right colon of patients in the probiotics and the placebo group, respectively. All subjects’ clinical data and stool samples were collected before, 2 weeks and 4 weeks after colonoscopic treatment. Results Twenty-nine subjects completed the follow-up. A significant difference was found in the frequency of defecation at 2 weeks, and the abdominal Visual Analog Score and Bristol stool scale at 4 weeks after probiotics treatment. The gastrointestinal symptom rating scale and IBS severity score decreased significantly and the IBS Quality of Life Instrument score increased 2 weeks after probiotics treatment (p < 0.05). The comprehensive therapeutic index was 70.0% and 44.4% in the probiotics group and the placebo group, respectively. The gut microbiota diversity was not significantly different at 2 and 4 weeks after treatment among the groups. Ratio of Firmicutes to Bacteroidetes decreased in the probiotics group. Conclusions The symptoms of IBS-D could be improved by probiotics administration via colonoscopy. The study was registered on chictr.org.cn (ChiCTR-IPR-17010411). Graphical Abstract


  • Retrospective study of 189 cases of acute perforated peptic ulcer: safety and efficacy of over-the-scope-clip based endoscopic closure

    by Wei-Jia You, Ting-Ting Lian, Ou Qian, Jing-Jing Wei, Ze-Hao Zhuang

    Background To compare the clinical outcomes in patients with acute perforated peptic ulcer (PPU) treated with over-the-scope clip (OTSC), non-surgical, and surgical interventions, and to explore the effectiveness and safety of OTSC closure. Methods Hospital stay, antibiotic use, diet resumption time, and mortality rate were analyzed retrospectively. Binary Logistic regression analysis was used to identify the risk factors influencing PPU complicated with sepsis. Results Patients were divided into three treatment groups: OTSC (n = 62), non-surgical (n = 72), and surgical (n = 55) groups. The median time (IQR) from symptom onset to admission was 9.0 (4–23) h. 88.71% (55/62) of the patients in In the OTSC group underwent OTSC closure within 24 h (median [IQR] time: 14.5 [7.00–30.25] h). The perforation diameters in the OTSC and surgical groups were 9.87 mm ± 5.97 mm and 8.55 mm ± 6.17 mm, respectively. The median (IQR) hospital stays in the OTSC (9.50 [7.00–12.25] days) and non-surgical group (9.00[7.00–13.00]days) were similar (p > 0.05), but shorter than that in surgical group (12.00[10.00–16.00]days), (p < 0.05). The median duration of antibiotic use was shorter in the OTSC group (7.00[3.00–10.00]) than in the non-surgical group (9.00[7.00–11.00]) and surgical group (11.00[9.00–13.00]) ( p < 0.05); and the time to resume oral feeding was shorter in the OTSC group (4.00[2.00–5.25]) than in the non-surgical group (7.00[6.13–9.00]) and surgical group (8.00[6.53–10.00]), respectively ( p < 0.05). No mortality difference among groups (p = 0.109) was found. Lower albumin level at admission, older age, and elevated creatinine levels were associated with increased sepsis risk, with OR(95%CI) of 0.826 (0.687–0.993), 1.077 (1.005–1.154), and 1.025 (1.006–1.043), respectively (all p < 0.05). Conclusion OTSC closure improves clinical outcomes of acute PPU patients without sepsis. Age, hypoalbuminemia, and baseline renal dysfunction increase the risk of sepsis, while mortality was associated with sepsis and multiorgan dysfunction.


  • Open Access

    Clinical Pathway for Enhanced Recovery in the Management of Non-Variceal Upper Gastrointestinal Bleeding: A Randomized Controlled Trial

    by Yan-Yan Zhang, Qiao-Xian Zhang, Jun-Ting Li, Yan Wang, Ze-Hao Zhuang, Jia-Yuan Zhuang

    Purpose: To explore the effects of the clinical pathway on the outcomes of patients with non-variceal upper gastrointestinal bleeding. Materials and Methods: Randomized controlled trial. The study was conducted in two medical centers in China from 1 June 2022 to 31 December 2022. Patients with a diagnosis of non-variceal upper gastrointestinal bleeding who provided written informed consent were consecutively assigned to the intervention group. The patients in the intervention group were treated using the clinical pathway, while the control group received routine care and follow-up. Time, cost, complications, and prognostic indicators were analyzed. Intentional-to-treat analysis and per-protocol analysis were used for data analysis. Results: A total of 114 eligible patients with non-variceal upper gastrointestinal bleeding were randomly divided into two groups and included in the intention-to-treat analysis. In addition, 106 patients were included in the per-protocol analysis. The median age of the 106 patients was 57 years (range, 18– 92 years) and 83.0% were male. There were no significant differences between groups regarding the baseline characteristics. The intervention group demonstrated a statistically significantly shorter length of stay, lower hospital cost (ie, cost during hospitalization, cost in the emergency room, and cost in the ward), significantly fewer cases of complications, and a higher level of patient satisfaction when compared with the control group. There was no significant difference between the two groups in the rates of transfusion, repeat endoscopy, rebleeding readmission, and mortality. Conclusion: The implementation of the clinical pathway for patients with non-variceal upper gastrointestinal bleeding may help improve patient outcomes and satisfaction. Trial Registration Number: ChiCTR2200060316. Registration Link: https://www.chictr.org.cn/.


  • Retraction
    Open Access

    Retraction Note: The effect of n-3/n-6 polyunsaturated fatty acids on acute reflux esophagitis in rats

    by Ze-Hao Zhuang, Jing-Jing Xie, Jing-Jing Wei, Du-Peng Tang, Li-Yong Yang

  • Open Access

    Exfoliative esophageal bleeding caused by blind placement of a nasogastric tube: Two cases and a literature review

    by Qi-Qiang Huang, Jing-Jing Wei, Ze-Hao Zhuang

    Transnasal intubation is a clinical operation usually performed blindly at the bedside. Mild adverse events, such as epistaxis and tube misplacement, are relatively common. Esophageal bleeding or perforation and other serious adverse events are rare. In the present study, two cases of severe diffuse esophageal bleeding caused by the blind placement of a nasogastric tube are described. These cases were successfully treated using a covered metal stent or Sengstaken-Blakemore tube. A review of the literature regarding the possible causes of such adverse events and the potential endoscopic treatments for severe hemorrhage are discussed.


  • Open Access

    Elevated Pro-inflammatory Cytokine Levels in Acute Reflux Esophagitis Are Reduced by 1,25 Dihydroxy Vitamin D3

    by Jingjing Wei, Jun Zhang, Ying Jiang, Tingting Lian, Peihong Zhang, Robert M. Hoffman, Guangwei Zhu, Zehao Zhuang

    Background/Aim: Gastric acid reflux into the esophagus can cause irritation and inflammation of the esophagus and progress to reflux esophagitis (RE). Vitamin D3 (VitD3) has anti-inflammatory effects and plays an important regulatory role in adaptive and innate immunity. We hypothesized that VitD3 may play a protective role in RE. Materials and Methods: Seventy male Sprague–Dawley rats were used, and acute RE (n=35) or chronic RE (n=35) were surgically induced. The effects of different doses of VitD3 on morphological changes and alteration of pro-inflammatory cytokine levels were examined in the rat models. Western blot analysis was performed to determine protein expression levels of IL-1β, IL-6, and IL-8 in esophageal tissues. Serum levels of VitD3 and calcium were determined using enzyme-linked immunosorbent assays. Results: The protein expression of pro-inflammatory cytokines IL-1β, IL-6, and IL-8 was found significantly increased in RE. VitD3 treatment significantly reduced the levels of these pro-inflammatory cytokines in both the low-dose and high-dose VitD3 groups compared to control groups in acute RE, but not chronic RE. Macrographic and histopathological examination revealed various degrees of esophageal impairment in rats following surgical induction of acute or chronic RE in rats. These impairments were not improved by VitD3. Morphological grading of esophageal mucosa showed no significant differences between acute and chronic RE. Elevated serum levels of calcium were observed after VitD3 treatment. Conclusion: IL-1β, IL-6, and IL-8 levels were significantly elevated in RE. The abnormal increase in these important pro-inflammatory cytokines was suppressed by VitD3 in the rat models of acute RE. These novel findings suggest a potential protective role of VitD3 in early-stage RE.